Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Por Gold, Ralf, Comi, Giancarlo, Palace, Jacqueline, Siever, Arno, Gottschalk, Rebecca, Bijarnia, Mahendra, von Rosenstiel, Philipp, Tomic, Davorka, Kappos, Ludwig
Publicado em 2013

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Por Kira, Jun-ichi, Itoyama, Yasuto, Kikuchi, Seiji, Hao, Qi, Kurosawa, Takayoshi, Nagato, Kazuo, Tsumiyama, Isao, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Saida, Takahiko
Publicado em 2014

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

Por Schulte, Johannes H., Marschall, Tobias, Martin, Marcel, Rosenstiel, Philipp, Mestdagh, Pieter, Schlierf, Stefanie, Thor, Theresa, Vandesompele, Jo, Eggert, Angelika, Schreiber, Stefan, Rahmann, Sven, Schramm, Alexander
Publicado em 2010

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

Por Radue, Ernst-Wilhelm, Barkhof, Frederik, Kappos, Ludwig, Sprenger, Till, Häring, Dieter A., de Vera, Ana, von Rosenstiel, Philipp, Bright, Jeremy R., Francis, Gordon, Cohen, Jeffrey A.
Publicado no Neurology (2015)

Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial

Por Kappos, Ludwig, O'Connor, Paul, Radue, Ernst-Wilhelm, Polman, Chris, Hohlfeld, Reinhard, Selmaj, Krzysztof, Ritter, Shannon, Schlosshauer, Rolf, von Rosenstiel, Philipp, Zhang-Auberson, Lixin, Francis, Gordon
Publicado no Neurology (2015)

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Por Cohen, Jeffrey A, Khatri, Bhupendra, Barkhof, Frederik, Comi, Giancarlo, Hartung, Hans-Peter, Montalban, Xavier, Pelletier, Jean, Stites, Tracy, Ritter, Shannon, von Rosenstiel, Philipp, Tomic, Davorka, Kappos, Ludwig
Publicado no J Neurol Neurosurg Psychiatry (2016)

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

Por Kappos, Ludwig, Radue, Ernst-Wilhelm, Comi, Giancarlo, Montalban, Xavier, Butzkueven, Helmut, Wiendl, Heinz, Giovannoni, Gavin, Hartung, Hans-Peter, Derfuss, Tobias, Naegelin, Yvonne, Sprenger, Till, Mueller-Lenke, Nicole, Griffiths, Sarah, von Rosenstiel, Philipp, Gottschalk, Rebecca, Zhang, Ying, Dahlke, Frank, Tomic, Davorka
Publicado no Neurology (2015)

Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

Por Wang, Jun, Thingholm, Louise B, Skiecevičienė, Jurgita, Rausch, Philipp, Kummen, Martin, Hov, Johannes R, Degenhardt, Frauke, Heinsen, Femke-Anouska, Rühlemann, Malte C, Szymczak, Silke, Holm, Kristian, Esko, Tönu, Sun, Jun, Pricop-Jeckstadt, Mihaela, Al-Dury, Samer, Bohov, Pavol, Bethune, Jörn, Sommer, Felix, Ellinghaus, David, Berge, Rolf K, Hübenthal, Matthias, Koch, Manja, Schwarz, Karin, Rimbach, Gerald, Hübbe, Patricia, Pan, Wei-Hung, Sheibani-Tezerji, Raheleh, Häsler, Robert, Rosenstiel, Philipp, D’Amato, Mauro, Cloppenborg-Schmidt, Katja, Künzel, Sven, Laudes, Matthias, Marschall, Hanns-Ulrich, Lieb, Wolfgang, Nöthlings, Ute, Karlsen, Tom H, Baines, John F, Franke, Andre
Publicado no Nat Genet (2016)